# Affect Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/affect-therapeutics

- Industry: Healthcare IT
- Headquarters: McLean, US
- Website: www.affect.com/
- Total disclosed funding: $44M
- Latest round: Series B (Nov 5, 2025)
- Investors on record: 8

## About

Based in Virginia, US, and founded in 2020 by CEO Kristin Muhlner, Jeff De Flavio, and Rachel Lin, Affect Therapeutics, Inc., a.k.a. Affect Therapeutics operates as a developer of a healthtech software platform that provides digital solutions for people with alcohol and drug addiction. In November 2025, Affect Therapeutics, Inc. raised USD 26 million in series B funding led by new investor Allumia Ventures, with participation from another new investor Limitless Ventures. Returning investors ARTIS Ventures, City Light Capital, and LifeArc also participated in the round.

The company provides a smartphone application that reimagines drug and alcohol addiction treatment via an integrated treatment program. The application offers an integrated all-digital addiction recovery program that offers professional support and financial rewards as individuals succeed in treatment.

The company plans to use the November 2025 funding to expand its virtual clinic across more states, strengthen partnerships with Medicaid and commercial plans, and enhance integrated behavioral health services for substance use and mental health care.

## Funding rounds

- Series B, Nov 5, 2025, $26M — ARTIS Ventures, City Light Capital, Allumia Ventures, Limitless Ventures, LifeArc
- Series A, Dec 16, 2022, $18M — ARTIS Ventures, City Light Capital, Samsung NEXT Ventures, AlleyCorp, What If Ventures, LifeArc

## Investors

- ARTIS Ventures (https://capitalatlas.ai/funds/artis-ventures) — Series A, Series B
- City Light Capital (https://capitalatlas.ai/funds/city-light-capital) — Series A, Series B
- Samsung NEXT Ventures (https://capitalatlas.ai/funds/samsung-next-ventures) — Series A
- AlleyCorp — Series A
- What If Ventures (https://capitalatlas.ai/funds/what-if-ventures) — Series A
- LifeArc (https://capitalatlas.ai/funds/lifearc) — Series A, Series B
- Allumia Ventures (https://capitalatlas.ai/funds/allumia-ventures) — Series B
- Limitless Ventures (https://capitalatlas.ai/funds/limitless-ventures) — Series B